Availability of Orkambi and other CF drugs on the NHS: further documents

30 January 2019

On Thursday 20 December the Health and Social Care Committee published documents received from Vertex Pharmaceuticals, NHS England and the National Institute for Health and Care Excellence (NICE) in response to its request.

The Committee invited the parties to make further comments on the documents the Committee received. These comments have now been made available below.

Further to the documents received, the Committee has announced a public hearing on the subject for Thursday 7 March. Anybody who wishes to bring information to the Committee's attention ahead of the session is invited to do so via the submission form.

Document from NHS England

Letter dated 16 January 2019

Document from NICE

Letter dated 15 January 2019

Documents from Vertex Pharmaceutical (Europe) Ltd

Letter dated 16 January 2019
Letter from NICE to Vertex dated 13 December 2018
Letter from Vertex to NHSE dated 16 January 2019
Letter from Vertex to NICE dated 16 January 2019

Further information

Image: iStockphoto